Project Grant R03HL177041
- Federal Grant Award Summary The Johns Hopkins University received a $245,624 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), effective September 5, 2025, through August 31, 2027. This secondary data analysis project applies unsupervised machine learning methodologies to the Pulmonary Vascular Disease Phenomics (PVDOMICS) dataset and Johns Hopkins PH Registry to identify novel patient clusters among...
- Federal Project Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), awarded The Johns Hopkins University a $1.488 million Project Grant effective August 1, 2025, through May 31, 2029. Under the direction of Dr. Alexander Hillel and co-investigator Dr. Ramana Sidhaye at Johns Hopkins School of Medicine's Department of Otolaryngology-Head & Neck Surgery, the award funds research aimed at understanding...
- Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded The Johns Hopkins University a $1,035,944 Project Grant effective September 23, 2025, through June 30, 2029, under the Cardiovascular Diseases Research program (CFDA 93.837). The project, titled "Bangladesh Infant Lung Development-ACS for Improving Outcomes in Preterm Newborns" (BILDING-ACTION), leverages two rigorous World Health Organization (WHO) randomized controlled trials to establish a...
- Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded Johns Hopkins University a Project Grant of $180,488 under the Cardiovascular Diseases Research program (CFDA 93.837) effective March 1, 2026 through September 15, 2027. This research initiative investigates severe acute respiratory failure (ARF) in cancer patients treated with immune checkpoint inhibitors (ICIs), addressing a critical gap in understanding the clinical and biomarker risk factors...
- Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded The Johns Hopkins University a $514,484 Project Grant (CFDA 93.837: Cardiovascular Diseases Research) on August 24, 2025, for research investigating the role of kynurenine pathway metabolism in pulmonary arterial hypertension (PAH). The research will be conducted through June 30, 2030, at Johns Hopkins' Maryland facilities. The project delivers basic and translational research services focused on...
- Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded The Johns Hopkins University a $638,176 Project Grant (CFDA 93.837 – Cardiovascular Diseases Research) effective May 1, 2026 through February 28, 2029 to conduct basic research investigating thrombospondin-1 (TSP-1) as a therapeutic target for heart failure with preserved ejection fraction (HFpEF). The research will identify mechanisms underlying cardiac structural changes in HFpEF through sex-specific...
- Federal Project Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded The Johns Hopkins University a Project Grant of $248,919 (awarded June 1, 2026; completion April 30, 2029) under the Cardiovascular Diseases Research program (CFDA 93.837) to investigate muscle metabolism and exercise intolerance in patients with heart failure and preserved ejection fraction (HFpEF). The research will employ a novel interleaved magnetic resonance spectroscopy/magnetic resonance...
- Federal Project Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded The Johns Hopkins University a $379,509 Project Grant effective July 1, 2026 through June 30, 2030 under the Cardiovascular Diseases Research program (CFDA 93.837). The project delivers research and development of mesenchymal stem cell (MSC) therapies with enhanced immunosuppressive efficacy for treating graft-versus-host disease (GVHD). The primary deliverable is the identification and provision of...
- Federal Project Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded Johns Hopkins University a $392,233 Project Grant effective August 1, 2025, through May 31, 2030, under the Cardiovascular Diseases Research program (CFDA 93.837). This award funds research training and mentored career development for Dr. Lee Goeddel, a cardiac anesthesiologist and intensivist, to investigate the relationship between cardiac output, renal perfusion, and acute kidney injury (AKI)...
- Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded The Johns Hopkins University a Project Grant totaling $198,654 under the Cardiovascular Diseases Research program (CFDA 93.837) effective August 1, 2025, through July 31, 2030. This award supports a five-year research initiative investigating the role of diet quality and food insecurity as modifiable factors linking socioeconomic status to Chronic Obstructive Pulmonary Disease (COPD) morbidity and...
The National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), awarded The Johns Hopkins University a Project Grant of $233,250 effective July 1, 2026, through June 30, 2028. This award supports the development of a reproducible large animal translational model using swine to investigate acute lung injury (ALI) and evaluate the therapeutic efficacy of extracorporeal membrane oxygenation (ECMO) as a respiratory support intervention. The project addresses a critical clinical gap by advancing understanding of optimal ECMO management strategies and lung recovery mechanisms in severe ALI, where mortality approaches 40% despite standard lung-protective ventilation strategies. The deliverables include establishment of a validated swine model of ALI that enables systematic investigation of how ECMO modulates disease progression and mechanisms of lung injury. By creating this reproducible translational platform, the research will inform clinical approaches to balance ventilatory support with lung protection, potentially improving outcomes for patients with severe respiratory failure who require extracorporeal respiratory support. Research will be conducted at Johns Hopkins University's Baltimore, Maryland facility.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $233.3k | 6/23/26 |